Cancer chemotherapy /

Por Pinedo, H. M.
Publicado em 1981.

The High Tide of Cancer Research in Europe

Por Johnston, Patrick G., Pinedo, H.M.
Publicado em 2011

Commentary: Fifty Years of the European Organisation for Research and Treatment of Cancer (EORTC) – Making the Difference for the European Oncology Community

Por Meunier, Françoise, Lawler, Mark, Pinedo, H.M.
Publicado em 2012

In vitro and in vivo studies on the combination of Brequinar sodium (DUP-785; NSC 368390) with 5-fluorouracil; effects of uridine.

Por Peters, G. J., Kraal, I., Pinedo, H. M.
Publicado em 1992

Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.

Por Los, G., van Vugt, M. J., Pinedo, H. M.
Publicado em 1994

Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.

Por Boven, E., Erkelens, C. A., Luning, M., Pinedo, H. M.
Publicado em 1990

Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts

Por Kolfschoten, G M, Hulscher, T M, Pinedo, H M, Boven, E
Publicado em 2000

Salicylate-induced consumption coagulopathy.

Por Pinedo, H M, van de Putte, L B, Loeliger, E A
Publicado em 1973

Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.

Por Broxterman, H. J., Pinedo, H. M., Schuurhuis, G. J., Lankelma, J.
Publicado em 1990

The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts.

Por Boven, E., Hendriks, H. R., Erkelens, C. A., Pinedo, H. M.
Publicado em 1992

European Perspectives: A Dialogue with the European Oncology Community

Por Le Chevalier, Thierry, Conte, Pierfranco, Johnston, Patrick G., Pinedo, H.M.
Publicado em 2012

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer.

Por Boven, E., Schipper, H., Erkelens, C. A., Hatty, S. A., Pinedo, H. M.
Publicado em 1993

Human tumour clonogenicity in agar is improved by cell-free ascites.

Por Uitendaal, M. P., Hubers, H. A., McVie, J. G., Pinedo, H. M.
Publicado em 1983

Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.

Por Kievit, E., Pinedo, H. M., Schlüper, H. M., Haisma, H. J., Boven, E.
Publicado em 1996

Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.

Por Molthoff, C. F., Pinedo, H. M., Schlüper, H. M., Nijman, H. W., Boven, E.
Publicado em 1992

Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.

Por Nauta, M. M., Boven, E., Schlüper, H. M., Erkelens, C. A., Pinedo, H. M.
Publicado em 1986

Letter: Acute myelofibrosis and chromosome damage after procarbazine treatment.

Por Pinedo, H M, Van Hemel, J O, Vrede, M A, Van der Sluys Veer, J
Publicado em 1974

Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2.

Por Baars, J. W., Coenen, J. L., Wagstaff, J., van der Valk, P., Pinedo, H. M.
Publicado em 1992

DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?

Por Smitskamp-Wilms, E., Giaccone, G., Pinedo, H. M., van der Laan, B. F., Peters, G. J.
Publicado em 1995

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.

Por Linn, S. C., Honkoop, A. H., Hoekman, K., van der Valk, P., Pinedo, H. M., Giaccone, G.
Publicado em 1996